Recruiting Hypertension Studies in New York
Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)
Researchers are looking for new ways to treat people with a type of pulmonary hypertension called combined postcapillary and precapillary pulmonary hypertension (Cpc-PH). This study focuses on Cpc-PH ...
Mono vs. Dual Therapy for Pediatric Pulmonary Arterial Hypertension
The investigators' central hypothesis is that early combination therapy with two PAH-specific oral therapies that have been shown to be well tolerated in the pediatric population, sildenafil and bosen...
About Hypertension Clinical Trials in New York
Hypertension, or high blood pressure, is a common condition that increases the risk of heart disease, stroke, and kidney damage. Often called the "silent killer" because it usually has no symptoms. Management includes lifestyle modifications and medications to lower blood pressure.
There are currently 2 hypertension clinical trials recruiting participants in New York, NY. These studies are seeking a combined 230 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Johns Hopkins University. Clinical trial participation is free and participants receive study-related medical care at no cost.
Hypertension Clinical Trials in New York — FAQ
Are there hypertension clinical trials in New York?
Yes, there are 2 hypertension clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New York?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.
Are clinical trials in New York free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.
What hypertension treatments are being tested?
The 2 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for hypertension.
Data updated March 2, 2026 from ClinicalTrials.gov